Skip to content

Clinical trials

Epilepsies, Myoclonic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Myoclonic Country / region: Germany Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20162
20171
20191
20211
20223
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting4
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.3
Longboard Pharmaceuticals2
Takeda2
Hospices Civils de Lyon1
Loulou Foundation1
Stichting Epilepsie Instellingen Nederland1
Stoke Therapeutics, Inc1
UCB BIOSCIENCES, Inc.1
Zogenix, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Myoclonic13
Epilepsy7
Seizures5
Brain Diseases3
Lennox Gastaut Syndrome3
Neurodevelopmental Disorders2
Arrhythmias, Cardiac1
Sudden Unexpected Death in Epilepsy1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.